Moreover, as antisense systems are reported to function, not only in actively proliferating cells, but also in more primitive CML cells,45, 46 there is also a real prospect of suppression of BCR‐ABL1 mRNA in CML SCs. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.